Loading...
Extension Study of PF‐05280586, a Potential Rituximab Biosimilar, Versus Rituximab in Subjects With Active Rheumatoid Arthritis
OBJECTIVE: This extension study provided continued treatment to subjects with active rheumatoid arthritis who had participated for ≥16 weeks in a pharmacokinetic similarity study of PF‐05280586 (potential rituximab biosimilar). Objectives were to evaluate overall pharmacokinetics, pharmacodynamics,...
Na minha lista:
| Udgivet i: | Arthritis Care Res (Hoboken) |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6221032/ https://ncbi.nlm.nih.gov/pubmed/29692005 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acr.23586 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|